Exane Derivatives’s Stellantis STLA Stock Holding History

Exane Derivatives’s Portfolio STLA Stock Details STLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-886	Closed	-$158K	–	1086
2021 Q4	$158K	Sell	886 -1,872	-68%	-$36.1K	0.04%	379
2021 Q3	$610K	Buy	2,758 +288	+12%	+$5.7K	0.15%	149
2021 Q2	$489K	Sell	2,470 -2,036	-45%	-$38.3K	0.11%	185
2021 Q1	$733K	Buy	4,506 +3,024	+204%	+$50.8K	0.21%	107
2020 Q4	$317K	Sell	1,482 -13,785	-90%	-$203K	0.09%	237
2020 Q3	$10.3M	Sell	15,267 -2,685	-15%	-$29.9K	2.98%	5
2020 Q2	$19.9M	Buy	17,952 +6,909	+63%	+$59.7K	5.31%	1
2020 Q1	$23.7M	Buy	11,043 +520	+5%	+$6.16K	6.61%	1
2019 Q4	$4.99M	Sell	10,523 -4,457	-30%	-$64.4K	0.93%	23
2019 Q3	$8.76M	Buy	14,980 +3,150	+27%	+$42.2K	1.57%	13
2019 Q2	$7.34M	Buy	11,830 +540	+5%	+$7.84K	1.29%	13
2019 Q1	$8.78M	Buy	11,290 +4,228	+60%	+$65K	1.73%	10
2018 Q4	$10M	Sell	7,062 -903	-11%	-$14.5K	1.8%	11
2018 Q3	$4.61M	Buy	7,965 +3,637	+84%	+$64.3K	0.87%	19
2018 Q2	$7.12M	Sell	4,328 -460	-10%	-$10.1K	1.19%	19
2018 Q1	$1.09M	Sell	4,788 -2,559	-35%	-$56.1K	0.22%	118
2017 Q4	$10.4M	Sell	7,347 -364	-5%	-$6.4K	1.79%	13
2017 Q3	$13.4M	Buy	7,711 +2,374	+44%	+$32.8K	2.51%	8
2017 Q2	$3.53M	Sell	5,337 -1,616	-23%	-$17.2K	0.76%	29
2017 Q1	$1.49M	Buy	6,953 +1,552	+29%	+$16.7K	0.34%	69
2016 Q4	$612K	Buy	5,401 +908	+20%	+$6.79K	0.12%	140
2016 Q3	$3.03M	Buy	+4,493	New	+$29.5K	0.45%	54
2016 Q2	–	Sell	-3,936	Closed	-$2.07M	–	623
2016 Q1	$2.07M	Sell	3,936 -6,890	-64%	-$49.8K	0.27%	58
2015 Q4	$3.85M	Sell	10,826 -1,125	-9%	-$10.6K	0.53%	47
2015 Q3	$6.32M	Buy	11,951 +3,930	+49%	+$37.6K	0.8%	39
2015 Q2	$2.31M	Sell	8,021 -425	-5%	-$4.36K	0.25%	60
2015 Q1	$1.19M	Buy	8,446 +2,428	+40%	+$22.7K	0.13%	88
2014 Q4	$1.19M	Buy	+6,018	New	+$44.6K	0.17%	94

Other funds holding STLA

Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BOI

Bank of Italy Rome, Italy $2.21B AUM 9.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Exane Derivatives's STLA Position: Q2 2022 in Review

Exane Derivatives reduced its Stellantis (STLA) stake by 90% in Q2 2022, selling an estimated $3.83M and leaving 31,141 shares worth $381K. The position accounts for 0.22% of the portfolio, ranked #112.

Exane Derivatives first reported a position in STLA in Q1 2015 and has held it in 23 quarters since. The position peaked at $31.4M in Q4 2021. 333 funds tracked by Wall St. Rank hold STLA as of Q2 2022.

Exane Derivatives held 31,141 shares of Stellantis worth $381K as of Q2 2022.
Exane Derivatives sold 270,625 Stellantis shares in Q2 2022, an estimated $3.83M.
Stellantis made up 0.22% of Exane Derivatives's portfolio in Q2 2022, its #112 holding.
Exane Derivatives first reported a position in Stellantis in Q1 2015 and has held it in 23 quarters since.
Exane Derivatives's Stellantis position peaked at $31.4M in Q4 2021.
333 funds tracked by Wall St. Rank held Stellantis as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.